GSK plc Increase Decrease Through Net Exchange Differences Deferred Tax Liability Asset
GSK plc (GLAXF) reported Increase Decrease Through Net Exchange Differences Deferred Tax Liability Asset of GBP 79.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes › Income Taxes
ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset · last filed 2026-03-06
| Period end | Increase Decrease Through Net Exchange Differences Deferred Tax Liability Asset 12 month | Increase Decrease Through Net Exchange Differences Deferred Tax Liability Asset 12 month as first filed |
|---|---|---|
| 2025-12-31 | 79.00M GBP 20-F · filed 2026-03-06 | |
| 2024-12-31 | 30.00M GBP 20-F · filed 2026-03-06 | -30.00M GBP 20-F · filed 2025-03-03 |
| 2023-12-31 | -127.00M GBP 20-F · filed 2025-03-03 | |
| 2022-12-31 | -102.00M GBP 20-F · filed 2024-03-05 | |
| 2021-12-31 | -36.00M GBP 20-F · filed 2023-03-10 | |
| 2020-12-31 | -55.00M GBP 20-F · filed 2022-03-08 | |
| 2019-12-31 | 103.00M GBP 20-F · filed 2021-03-12 | |
| 2018-12-31 | 84.00M GBP 20-F · filed 2020-03-06 | |
| 2017-12-31 | -65.00M GBP 20-F · filed 2019-03-15 |